Clinical Trial Update: Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase 1/2 trial evaluating chemotherapy response monitoring with 18F-choline PET/CT in hormone-refractory prostate cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Queen's Medical Center | Conditions: Hormone Refractory Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-14